BPC-157 isn't FDA-approved for any indication

Antibodies The following antibodies were used: anti-TRIP12 (Proteintech, 25303, 1:1,000), antip-I-kB (Cell Signaling Technology, 9246 s, 1:1,000), antip-IKK (Cell Signaling Technology, 2078 s, 1:1,000), anti-I-B (Cell Signaling Technology, 4812 s, 1:1,000), antip-p65 (Cell Signaling Technology, 3033, 1:1,000), anti-HA (Cell Signaling Technology, 3724 s, 1:1,000), anti-FLAG (SIGMA, 7425, 1:1,000, or Cell Signaling Technology, 14793 s, 1:1,000), anti-TRAF2 (Abcam, ab-126758, 1:1,000), anti-OTUD5 (Cell Signaling Technology, 20087, 1:1,000), anti-ARMC7 (NOVUS, NBP1-82129, 1:1,000), anti-ZGPAT (Proteintech, 23203, 1:1,000), anti-GTF2B (Proteintech, 16467, 1:1,000), anti-MEAF6 (Themo Fisher Scientific, PA5-40704, 1:1,000), anti-ZBED1 (Proteintech, 26140, 1:1,000), anti-PRDM2 (Proteintech, 27718, 1:1,000), anti-NR2F2 (COUP-TFII) (Cell Signaling Technology, 6434 s, 1:1,000), anti-DHX32 (Proteintech, 68306-1-lg, 1:1,000), anti-Rad18 (Cell Signaling Technology, 9040 s, 1:1,000), anti-Actin (Santa Cruz Biotechnology, sc-47778, 1:1,000), anti-ubiquitin (P4D1, Santa Cruz Biotechnology, sc-8017, 1:1,000), anti-OTUD3 (Proteintech, 29622, 1:1000), anti-OTUD4 (Proteintech, 25070, 1:1000), anti-UBR5 (Santa Cruz Biotechnology, sc-515494, 1:1000), and anti-K48ubiquitin (Abcam, ab-140601, 1:1,000)

Impact of Central and Peripheral TRPV1 and ROS Levels on Proinflammatory Mediators and Nociceptive Behavior
MSCs and exosomes were isolated from the umbilical cord tissue of Whartons jelly
Gatica D, Lahiri V, Klionsky DJ